These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 25935517
1. Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report. Park MJ, Ganjoo KN, Ladd AL. J Hand Surg Am; 2015 Aug; 40(8):1620-4. PubMed ID: 25935517 [Abstract] [Full Text] [Related]
2. Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius. Li Z, Deng Z, Yang Y, Gao D, Zhang Q, Niu X, Liu W. J Orthop Surg Res; 2024 Sep 28; 19(1):607. PubMed ID: 39342379 [Abstract] [Full Text] [Related]
3. Denosumab for Bone Giant Cell Tumor of the Distal Radius. Tsukamoto S, Mavrogenis AF, Tanzi P, Leone G, Ciani G, Righi A, Akahane M, Honoki K, Tanaka Y, Donati DM, Errani C. Orthopedics; 2020 Sep 01; 43(5):284-291. PubMed ID: 32745221 [Abstract] [Full Text] [Related]
4. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab]. Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH. Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590 [Abstract] [Full Text] [Related]
5. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series. Müller DA, Beltrami G, Scoccianti G, Campanacci DA, Franchi A, Capanna R. World J Surg Oncol; 2016 Nov 04; 14(1):281. PubMed ID: 27809843 [Abstract] [Full Text] [Related]
6. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone. Wojcik J, Rosenberg AE, Bredella MA, Choy E, Hornicek FJ, Nielsen GP, Deshpande V. Am J Surg Pathol; 2016 Jan 04; 40(1):72-80. PubMed ID: 26414220 [Abstract] [Full Text] [Related]
7. Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone. Rutkowski P, Ferrari S, Grimer RJ, Stalley PD, Dijkstra SP, Pienkowski A, Vaz G, Wunder JS, Seeger LL, Feng A, Roberts ZJ, Bach BA. Ann Surg Oncol; 2015 Sep 04; 22(9):2860-8. PubMed ID: 26033180 [Abstract] [Full Text] [Related]
8. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery. von Borstel D, A Taguibao R, A Strle N, E Burns J. Skeletal Radiol; 2017 Apr 04; 46(4):571-578. PubMed ID: 28188337 [Abstract] [Full Text] [Related]
9. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India. Rekhi B, Verma V, Gulia A, Jambhekar NA, Desai S, Juvekar SL, Bajpai J, Puri A. Pathol Oncol Res; 2017 Jan 04; 23(1):157-164. PubMed ID: 27722984 [Abstract] [Full Text] [Related]
10. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone. Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS. Eur J Cancer; 2016 May 04; 59():1-12. PubMed ID: 26990281 [Abstract] [Full Text] [Related]
11. A case of pelvic giant cell tumor of bone, complete remission with denosumab: long duration of response. Bilgetekin I, Mammadkhanli O, Basal FB, Kandemir O, Canbay S, Oksuzoglu B. Anticancer Drugs; 2020 Jun 04; 31(5):533-535. PubMed ID: 31743134 [Abstract] [Full Text] [Related]
12. Response to Denosumab in 2 Children With Recurrent Giant Cell Tumor of the Bone With Pulmonary Metastasis. Reddy K, Ramirez L, Kukreja K, Venkatramani R. J Pediatr Hematol Oncol; 2021 Mar 01; 43(2):e215-e218. PubMed ID: 31714440 [Abstract] [Full Text] [Related]
13. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series. Girolami I, Mancini I, Simoni A, Baldi GG, Simi L, Campanacci D, Beltrami G, Scoccianti G, D'Arienzo A, Capanna R, Franchi A. J Clin Pathol; 2016 Mar 01; 69(3):240-7. PubMed ID: 26338802 [Abstract] [Full Text] [Related]
14. Recurrent giant cell tumour of the maxillary sinus and pterygoid process treated with denosumab. Rosa D, Dias RB, Salvador JC, Borges A. BMJ Case Rep; 2018 Sep 08; 2018():. PubMed ID: 30196254 [Abstract] [Full Text] [Related]
16. Immunohistochemical Characterization of Giant Cell Tumor of Bone Treated With Denosumab: Support for Osteoblastic Differentiation. Kerr DA, Brcic I, Diaz-Perez JA, Shih A, Wilky BA, Pretell-Mazzini J, Subhawong TK, Nielsen GP, Rosenberg AE. Am J Surg Pathol; 2021 Jan 08; 45(1):93-100. PubMed ID: 32773532 [Abstract] [Full Text] [Related]
17. Response evaluation of giant-cell tumor of bone treated by denosumab: Histogram and texture analysis of CT images. Yi J, Lee YH, Kim SK, Kim SH, Song HT, Shin KH, Suh JS. J Orthop Sci; 2018 May 08; 23(3):570-577. PubMed ID: 29429890 [Abstract] [Full Text] [Related]
18. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone]. Sørensen AL, Hansen RL, Jørgensen PH. Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237 [Abstract] [Full Text] [Related]
19. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone. Zhang RZ, Ma TX, Qi DW, Zhao M, Hu T, Zhang GC. Orthop Surg; 2019 Dec 05; 11(6):1101-1108. PubMed ID: 31762217 [Abstract] [Full Text] [Related]
20. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review. Tsukamoto S, Tanaka Y, Mavrogenis AF, Kido A, Kawaguchi M, Errani C. Clin Orthop Relat Res; 2020 May 05; 478(5):1076-1085. PubMed ID: 31794487 [Abstract] [Full Text] [Related] Page: [Next] [New Search]